Combined gossypol and zoledronic acid treatment results in synergistic induction of cell death and regulates angiogenic molecules in ovarian cancer cells

被引:25
作者
Atmaca, Harika [2 ]
Gorumlu, Gurbuz [1 ]
Karaca, Burcak [1 ]
Degirmenci, Mustafa [1 ]
Tunali, Didem [1 ]
Cirak, Yalcin [1 ]
Purcu, Duygu Unuvar [2 ]
Uzunoglu, Selim [2 ]
Karabulut, Bulent [1 ]
Sanli, Ulus A. [1 ]
Uslu, Ruchan [1 ]
机构
[1] Ege Univ, Sch Med, Tulay Aktas Oncol Hosp, Div Med Oncol, Izmir, Turkey
[2] Celal Bayar Univ, Mol Biol Sect, Dept Biol, Fac Sci & Arts, Muradiye, Manisa, Turkey
关键词
gossypol; zoledronic acid; OVCAR-3; MDAH-2774; angiogenic molecules; GROWTH-FACTOR VEGF; PROSTATE-CANCER; BREAST-CANCER; THYMIDINE PHOSPHORYLASE; COLON-CARCINOMA; GENE-EXPRESSION; IN-VITRO; THERAPY; BISPHOSPHONATES; EFFICACY;
D O I
10.1684/ecn.2009.0159
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
In the present study, we aimed to evaluate the possible synergistic, cytotoxic effects of combination treatment of gossypol and zoledronic acid, in human ovarian cancer cell lines, OVCAR-3 and MDAH-2774, and to elucidate the role of this novel combination treatment on angiogenesis-related molecules in ovarian cancer. The XTT cell viability assay was used for showing cytotoxicity. Both DNA fragmentation by ELISA assay and caspase 3/7 activity measurement were used for demonstrating apoptosis. To elucidate the angiogenic molecules affected by combination treatment, mRNA levels of angiogenic molecules were measured using the Human Angiogenesis RT2 Profiler (TM) PCR Array (SuperArray, Frederick, MD) in ovarian cancer cell lines, OVCAR-3 and MDAH-2774. The combined treatment resulted in significant, synergistic cytotoxicity, and induced apoptosis. This effect was observed to happen in a dose- and time-dependent manner. Moreover, the combination treatment of 10 mu M gossypol and 5 mu M zoledronic acid resulted in significant down-regulation (>= thee-fold) in mRNA levels of some pivotal angiogenic molecules in OVCAR-3 and MDAH-2774 cells as compared to the untreated control. However, this effect was different in the two ovarian cancer cell lines observed. Gossypol, in combination with zoledronic acid, may provide a rational treatment option for ovarian cancer, not only by direct inhibition of cell proliferation, but also inhibition of angiogenesis-related molecules.
引用
收藏
页码:121 / 130
页数:10
相关论文
共 43 条
[1]
Angiogenesis in epithelian ovarian cancer [J].
Bamberger, ES ;
Perrett, CW .
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 2002, 55 (06) :348-359
[2]
Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 [J].
Barleon, B ;
Sozzani, S ;
Zhou, D ;
Weich, HA ;
Mantovani, A ;
Marme, D .
BLOOD, 1996, 87 (08) :3336-3343
[3]
The FGF family: biology, pathophysiology and therapy [J].
Beenken, Andrew ;
Mohammadi, Moosa .
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (03) :235-253
[4]
Bilir A, 2002, NEOPLASMA, V49, P38
[5]
Brown NS, 1998, BIOCHEM J, V334, P1
[6]
Carrion L.A., 2004, REV ONCOL, V6, P462
[7]
QUANTITATIVE-ANALYSIS OF DOSE-EFFECT RELATIONSHIPS - THE COMBINED EFFECTS OF MULTIPLE-DRUGS OR ENZYME-INHIBITORS [J].
CHOU, TC ;
TALALAY, P .
ADVANCES IN ENZYME REGULATION, 1984, 22 :27-55
[8]
Gossypol: a contraceptive for men [J].
Coutinho, EM .
CONTRACEPTION, 2002, 65 (04) :259-263
[9]
Cytostatic and apoptotic effects of bisphosphonates on prostate cancer cells [J].
Dumon, JC ;
Journé, F ;
Kheddoumi, N ;
Lagneaux, L ;
Body, JJ .
EUROPEAN UROLOGY, 2004, 45 (04) :521-528
[10]
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer:: 5-year follow-up of the ABCSG-12 bone-mineral density substudy [J].
Gnant, Michael ;
Mlineritsch, Brigitte ;
Luschin-Ebengreuth, Gero ;
Kainberger, Franz ;
Kaessmann, Helmut ;
Piswanger-Soelkner, Jutta Claudia ;
Seifert, Michael ;
Ploner, Ferdinand ;
Menzel, Christian ;
Dubsky, Peter ;
Fitzal, Florian ;
Bjelic-Radisic, Vesna ;
Steger, Guenther ;
Greil, Richard ;
Marth, Christian ;
Kubista, Ernst ;
Samonigg, Hellmut ;
Wohlmuth, Peter ;
Mittlboeck, Martina ;
Jakesz, Raimund .
LANCET ONCOLOGY, 2008, 9 (09) :840-849